FDA seeks feedback on artificial intelligence in drug manufacturing

Regulatory NewsRegulatory NewsBiologics/ biosimilars/ vaccinesChemistry, Manufacturing and Controls (CMC)ComplianceNorth AmericaPharmaceuticalsProduct LifecycleQuality Assurance and ControlRegulatory Intelligence/Policy